Jun 7, 2025, 05:51 | Insight

Antonio Passaro on HERTHENA-Lung02 - Not your average ASCO 2025 update

Antonio Passaro, Medical Oncologist and a Medical Director with High Specialization Assignment at the European…

Jun 4, 2025, 23:14 | Societies

20 Posts Not to Miss from ASCO 2025

The ASCO Annual Meeting 2025 officially took place in Chicago from May 30 to June…

Jun 3, 2025, 12:30 | Societies

15 Posts Not to Miss from the 4th Day of ASCO 2025

The ASCO Annual Meeting 2025 is officially underway in Chicago! Running from May 30 to…

May 26, 2025, 10:33 | Blog

Antonio Passaro: IEO Announces Public “Di Martedì” Event on Clinical Research in Oncogene-Addicted NSCLC

Antonio Passaro, Medical Oncologist and a Medical Director with High Specialization Assignment at the European Institute…

May 18, 2025, 03:37 | Blog

Elvina Almuradova: Are we nearing a Paradigm Shift in early ER+/HER2- Breast Cancer?

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO, shared a post…

May 8, 2025, 14:00 | Insight

Elvina Almuradova on 2025 JAMA study linking stress sensitivity to increased lung cancer risk

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a…

May 5, 2025, 09:34 | Science

Elvina Almuradova: From Dose-Finding to Dose-Optimization in Early-Phase Oncology Clinical Trials

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared an article…

Apr 18, 2025, 14:07 | Blog

Humaid Al-Shamsi: Burjeel Cancer Institute signed an MoU with the European Institute of Oncology

Humaid Al-Shamsi, Founder and Director of Medical Oncology at Burjeel Medical City, shared a post…

Mar 28, 2025, 13:29 | Blog

Elvina Almuradova: Second interim analysis confirms the benefit from addition of Pembrolizumab to CRT

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a…

Mar 22, 2025, 07:26 | Science

Elvina Almuradova: Cemiplimab monotherapy vs chemotherapy as a first-line treatment with advanced NSCLC with PD-L1 expression

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared an…

Mar 8, 2025, 13:29 | Oncologist Near Me

Oncologist Near Me – Fedro Alessandro Peccatori: Leading Expert in Gynecological Oncology

Welcome to OncoDaily‘s special section “Oncologist Near Me” where we introduce prominent oncologists from around…

Mar 7, 2025, 03:20 | Science

Emre Yekedüz: Adding 6 months of ADT to SBRT significantly improved clinical PFS compared to SBRT alone

Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University, shared an article by Giulia…

Mar 4, 2025, 11:18 | Blog

Elvina Almuradova: ENHERTU Brings New Hope for Gastric Cancer

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a…

Feb 28, 2025, 15:34 | Blog

CancerWorld welcomes their Co-Editors-in-Chief

CancerWorld shared a post on LinkedIn: "A New Era for CancerWorld: Welcoming Our Co-Editors-in-Chief. We…

Feb 28, 2025, 14:50 | Blog

Elvina Almuradova: The FDA has granted fast track designation to 67Cu-SAR-bisPSMA for PSMA-positive mCRPC

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a…

Feb 27, 2025, 09:08 | Science

Elvina Almuradova: A Narrative Review of RAS Mutations in Early-Stage Colorectal Cancer

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared an…

Feb 26, 2025, 10:59 | Science

Elvina Almuradova: How GEMSTONE-303 differs from other trials

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared an…

Feb 22, 2025, 13:28 | Science

Elvina Almuradova: Immunotherapy for HPV-Associated Cancers

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared an article…

Feb 19, 2025, 17:30 | Science

Carmine Valenza: Tailoring treatments in premenopausal patients with Breast Cancer

Carmine Valenza, Medical Oncology Resident at the European Institute of Oncology, shared an article by…

Feb 17, 2025, 08:32 | Science

Elvina Almuradova: New Blood Test for Early Pancreatic Cancer Detection

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared an…

Feb 17, 2025, 08:28 | Blog

Francesca Spada: The 2025 ESO CAS-GI has concluded in Lugano

Francesca Spada, Medical Oncologist Assistant of Gastrointestinal Medical Oncology at the European Institute of Oncology (IEO),…

Feb 11, 2025, 08:15 | Science

Carmine Valenza: Platinum rechallenge in patients with platinum-resistant ovarian carcinoma

Carmine Valenza, Medical Oncology Resident at the European Institute of Oncology, shared an article on…

Feb 9, 2025, 15:39 | Blog

Dario Trapani: The great problem of global disparities in oncology

Dario Trapani, Medical Oncologist at the European Institute of Oncology (IEO), shared a post on…

Feb 9, 2025, 15:15 | Science

Elvina Almuradova: Survival outcomes for ERBB2-positive MBC patients with brain metastases

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared an…

Feb 8, 2025, 07:20 | Blog

Antonio Passaro: Honored to host the 20th International Preceptorship on Lung Cancer at IEO

Antonio Passaro, Medical Oncologist and a Medical Director at the European Institute of Oncology in…

Feb 1, 2025, 12:52 | Oncologist Near Me

Oncologist Near Me – Giuseppe Curigliano: A Prominent Specialist in Breast Cancer Clinical Trials and Research

Welcome to OncoDaily's special section “Oncologist Near Me” where we introduce prominent oncologists from around the world.…

Feb 1, 2025, 08:22 | Blog

Carmine Valenza, a member of the 2024-2025 PCE Outreach Team - Program in Clinical Effectiveness

Program in Clinical Effectiveness shared a post on LinkedIn: "Meet Carmine Valenza, a member of…

Jan 27, 2025, 08:54 | Blog

GISTs with PDGFRA mutation show lower 18F-FDG uptake compared to other molecular subtypes

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared an article…

Jan 14, 2025, 13:35 | Blog

Humaid Al-Shamsi: Two inspiring days with Giuseppe Curigliano at the European Institute of Oncology

Humaid Al-Shamsi, Founder and Director of Medical Oncology at Burjeel Medical City, posted on LinkedIn:…

Dec 31, 2024, 19:54 | Blog

Antonio Passaro: An important milestone in the treatment of advanced NSCLC with common EGFR mutations

Antonio Passaro, Medical oncologist at the European Institute of Oncology in Milan, posted on LinkedIn:…

Dec 22, 2024, 05:00 | Blog

Elvina Almuradova: Being a part of Giuseppe Curigliano's team is an invaluable scientific milestone for me

Elvina Almuradova, Associate Professor at Medicana Health Group, shared a post on LinkedIn: "Being a…

Dec 11, 2024, 09:20 | Blog

Meet Dr. Stefania Morganti - Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X: "Meet Dr. Stefania Morganti, an Advanced…

Nov 30, 2024, 09:18 | Blog

Antonio Passaro: Honored to be Recognized Among Leaders Shaping Oncology in 2024

Antonio Passaro, Medical oncologist at the European Institute of Oncology in Milan, shared a post…

Nov 18, 2024, 12:54 | Insight

Ovarian Function Suppression in Premenopausal Women With Breast Cancer

Dario Trapani, Medical oncologist at the European Institute of Oncology (IEO), shared a post by…

Nov 2, 2024, 02:35 | Insight

Carmine Valenza: ICIs in patients with metastatic TN-IBC

Carmine Valenza, Medical Oncology Resident at the European Institute of Oncology, shared a post on…

Oct 26, 2024, 12:34 | Blog

Migration, health and cancer with Raffaella Casolino

Dario Trapani, Medical Oncologist at the European Institute of Oncology (IEO) and a researcher in…

Oct 10, 2024, 15:57 | Insight

New ESMO Open editorial on Immunotherapy in breast cancer

ESMO Open shared a recent article by Paola Zagami on X: "Immunotherapy in the treatment landscape…

Oct 7, 2024, 09:18 | Blog

Dario Trapani: Addressing global challenges in cancer control for 1 community in 1 world at ESMO

Dario Trapani shared a post on X: “Can’t be more grateful to The European Society for Medical…

Aug 29, 2024, 16:53 | Insight

Dario Trapani: Very informative story on how clinical trials have been so far "tolerated" in their design

Dario Trapani shared a post on X about a paper by Vinay Prasad et al.…

Aug 29, 2024, 16:15 | Drugs

Antonio Passaro: European Commission approves amivantamab

Antonio Passaro shared on LinkedIn: "I'm proud to announce that, yesterday August 27, the European…

Aug 12, 2024, 22:06 | Insight

Lorenzo Guidi: How to treat CUPs with GI profile

Lorenzo Guidi, Medical Oncology Resident at the European Institute of Oncology (IEO), shared on X…

Aug 10, 2024, 14:02 | Insight

Veronica Coppini: Our latest publication disparities in Central and Eastern European countries

Veronica Coppini, Researcher at the European Institute of Oncology, shared on LinkedIn: "I'm thrilled to…

Jul 26, 2024, 08:11 | Blog

Federico Mastroleo: Choose Radiation Oncology!

Federico Mastroleo, Radiation Oncologist at IEO European Institute of Oncology, shared a post on X: "The Concorso…

Jul 19, 2024, 22:55 | Blog

What after Osimertinib failure?

Abhishek Pathak, Professor at the Indian Army, shared a post on X: "What after Osimertinib…

Jul 12, 2024, 15:04 | Blog

Dario Trapani: Essential part of sport that should be of inspiration 4 oncology

Dario Trapani, Medical Oncologist at European Institute of Oncology, shared on X: “There's an essential…

Jul 9, 2024, 03:40 | Insight

Dario Trapani: Cancer in humanitarian setting

Dario Trapani, Medical Oncologist at European Institute of Oncology, shared on X: “Cancer in humanitarian setting:…

Jul 7, 2024, 17:28 | Insight

Cristiane D. Bergerot: Unmet social needs in cancer care across HIC and LMIC

Cristiane D. Bergerot shared on X: "Our study in JCO Global Oncology explores financial toxicity…

Jun 30, 2024, 12:05 | Insight

The situation around GEP-MiNENs in Italy

Two studies from Italy present 20-year-old real-world data on patients with GEP-MiNENs treated with chemotherapy…

Jun 26, 2024, 03:41 | Insight

Paolo Tarantino: Opportunities to improve outcomes for early recurrent TNBC

Paolo Tarantino shared a post on X: . "Early recurrent TNBC (Triple-Negative…

Jun 23, 2024, 13:08 | Drugs

Capivasertib is now approved in EU for HR+/HER2- breast cancer

Paolo Tarantino shared a post on X: "Capivasertib is now approved in EU for the…

Jun 21, 2024, 04:41 | Insight

Davide Ciardiello: Cetuximab and Avelumab in patients with colorectal cancer liver metastasis

Davide Ciardiello, Oncologist at the Medical Oncology Division of Gastrointestinal and Neuroendocrine Tumors at European…

Jun 15, 2024, 16:02 | Dialogues

Oncodaily Talks: Dialogue with Giuseppe Curigliano, hosted by Chandler Park

OncoDaily Talks gathers people worldwide to discuss challenges in cancer care. We share creative solutions…

Jun 5, 2024, 15:33 | Insight

Giuseppe Curigliano: Excited that the DESTINY-06 trial was presented at ASCO2024

Giuseppe Curigliano shared on LinkedIn: “Excited to share that the DESTINY-06 trial was presented at…

Jun 5, 2024, 06:27 | Blog

Giuseppe Curigliano: Proud to serve on the Educational Committee for ASCO2024

Giuseppe Curigliano shared on LinkedIn: . "Proud to serve on…

Jun 5, 2024, 04:25 | Blog

Giuseppe Curigliano: Excited to see NBC News highlight the groundbreaking results of DESTINY-06

Giuseppe Curigliano reposted Erika Hamilton's post on LinkedIn, adding: . "Excited to see NBC…

Jun 4, 2024, 12:39 | Blog

Giuseppe Curigliano: Together, we can achieve more!

Giuseppe Curigliano shared on LinkedIn: . "Investing in the next generation of oncologists…

Jun 2, 2024, 09:05 | Blog

Giuseppe Curigliano: Celebrating Gender Equity and Inclusion with Dr. Don S. Dizon at ASCO24

Giuseppe Curigliano shared on LinkedIn: "Celebrating Gender Equity and Inclusion with the inspiring Dr. Don…

May 28, 2024, 14:34 | Drugs

Paolo Tarantino: Impressive activity with tucatinib plus trastuzumab for HER2-mutated breast cancer

Paolo Tarantino shared on X: "Impressive activity with tucatinib plus trastuzumab for HER2-mutated breast cancer.…

May 23, 2024, 14:29 | Societies

The names of the candidates running for the ESMO Presidency 2027-2028 have been announced

The names of the candidates running for the ESMO Presidency 2027-2028 have been announced. Find…

May 18, 2024, 02:12 | Blog

Paolo Tarantino: Important subanalysis of SOFT/TEXT presented by Otto Metzger

Paolo Tarantino shared on X: "Important subanalysis of SOFT/TEXT presented by Otto Metzger from Dana-Farber’s…

May 17, 2024, 15:13 | Societies

Elisabetta Munzone: TIP poster PREcoopERA trial for premenopausal women with early breast cancer

Elisabetta Munzone, Medical oncologist and Breast Cancer specialist at the European Institute of Oncology, shared…

May 13, 2024, 07:12 | Blog

Paolo Tarantino: DESTINY-Breast06 will be presented on 6/2 at ASCO24 by my friend and mentor of many years Giuseppe Curigliano

Paolo Tarantino shared on X: "DESTINY-Breast06 will be presented on 6/2 at ASCO24 by my…

Apr 29, 2024, 20:00 | Opinion

Erika Hamilton: Really feel like we don't need to be testing for HER-2 for TDXd in breast cancer

Erika Hamilton shared a post by Giuseppe Curigliano, Chief of the Clinical Division of Early…

Apr 17, 2024, 17:32 | Blog

Pam Mangat-Dhaliwal: Thrilled to participate in the second ASCO-AIOM International Clinical Research Course

Dario Trapani, Medical oncologist at the European Institute of Oncology (IEO), shared a post by Pam Mangat-Dhaliwal, Division…

Apr 15, 2024, 13:28 | Insight

Antonio Passaro: Release of our editorial, co-authored with Peters Solange, focusing on the groundbreaking ALINA study

Antonio Passaro, Medical Oncologist at European Institute of Oncology, shared on LinkedIn: ''I am thrilled…

Apr 2, 2024, 12:50 | Blog

Antonio Passaro: Key milestones in cancer biomarker research and future avenues for enhancing the management of patients with solid tumors

Antonio Passaro, Medical Oncologist at the European Institute of Oncology, shared a post on LinkedIn:…

Mar 30, 2024, 11:05 | Dialogues

The Comfort Corner #1: Dialogue with Matti Aapro, hosted by Martin Harutyunyan

Welcome to "The Comfort Corner" - a palliative care series that brings together medical professionals…

Mar 23, 2024, 15:20 | Blog

Giuseppe Curigliano: Grateful to Stella Kyriakides Commissioner for Health at European Commission for visiting European Institute of Oncology (IEO)

Giuseppe Curigliano, Chief of the Clinical Division of Early Drug Development at European Institute of…

Jan 8, 2024, 15:10 | Blog

Khalid El Bairi: This book is a labor of love aimed at advancing cancer research and supporting patients

Khalid El Bairi, Founder of The Cancer Biomarkers Working Group, shared a post on LinkedIn:…

Oct 2, 2023, 22:37 | Insight

Paolo Tarantino: Antibody drug conjugates (ADCs) are leading to relevant survival improvements for multiple types of cancer.

Paolo Tarantino, MD and researcher at the European Institute of Oncology and clinical research fellow…

Aug 15, 2023, 09:15 | Insight

Paolo Tarantino: Delivering chemo via HER2- and Trop2-targeted Antibody-drug conjugates (ADCs) has reshaped the way we treat Metastatic breast cancer (MBC)

Paolo Tarantino, MD, Clinical Research Fellow at Dana-Farber Cancer Institute, stated on Twitter: "Delivering chemo…